1.
Lancet
; 1(7917): 1169-70, 1975 May 24.
Artículo
en Inglés
| MEDLINE
| ID: mdl-48779
RESUMEN
In-vivo studies have demonstrated antiallergic properties in doxantrazole when given orally to rats. These properties were confirmed in work with in-vitro preparations. No significant animal toxicity has been detected. 200 mg. given by mouth inhibited the immediate-type asthmatic response in volunteer patients challenged with specific antigen.